Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Karim S. Fizazi
Based on 150 articles published since 2007
||||
Expertise Level
The expertise of Karim S. Fizazi ranks in the
  • Top 0.0046%
  • ... of 131,386 published authors worldwide on Prostatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 150 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Fizazi, K   ·   Fizazi, Karim   ·   Fizazi, Karim S
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2017
  • MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: · MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. · Salford Royal NHS Foundation Trust, Salford, UK. · Gustave-Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, Villejuif 94800, France. · Janssen Research & Development, San Diego, CA, USA. · Cardiff University, School of Medicine, Cardiff, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28800492
  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · National Cancer Institute, Vilnius, Lithuania. · Department of Oncology, Herlev Hospital, Herlev. · Department of Oncology, Aalborg University Hospital, Aalborg, Denmark. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · INSERM, UMR1098, Besançon. · Medicine, Centre Léon Bérard, Lyon, France. · Department of Oncology & Hematology, Azienda University Hospital, Modena, Italy. · Dana-Farber/Brigham and Women's Cancer Center, Boston, USA. · Department of Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of General Medical Oncology, University Hospitals Leuven, Leuven. · KU Leuven, Leuven, Belgium. · Urocentrum, Prague, Czech Republic. · General Oncology Department, Centre Oscar Lambret, Lille, France. · Lithuanian University of Health Sciences Hospital, Kaunas, Lithuania. · Gabinet Urologiczny, Gdynia, Gdansk, Poland. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Ipsen Innovation, Les Ulis, France. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Pubmed 29059273
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Département de radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address: · Service de biostatistiques, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Département de radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Groupe d'étude des tumeurs urogénitales, Unicancer, 101, rue de Tolbiac, 75654 Paris cedex 13, France. · Département de médecine oncologique, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Pubmed 28869198
  • SESSTIM, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Medical Oncology Department, Georges Pompidou Hospital, Rene Descartes University, Paris, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · UNICANCER, Paris, France. · Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France; Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28780479
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
  • US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. Electronic address: · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Oncology Hematology Care, Inc., Cincinnati, OH, USA. · US Oncology, Cancer Centers of North Carolina, Raleigh, NC, USA. · Texas Oncology, Austin, TX, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Uro-Oncology, Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie, Warsaw, Poland. · Celgene Corporation, Summit, NJ, USA. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. · Pubmed 27522164
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
  • Institut Gustave Roussy, Villejuif, France · BC Cancer Agency, Vancouver, BC, Canada · Pubmed 29083131
2016
  • MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK. · Institut Gustave Roussy, Paris, France. · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Warwick Cancer Research Unit, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Lank Center for Genitourinary Cancer, Dana-Farber Cancer Institute, Boston, MA, USA. · Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26718929
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: · Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. · Radiation Oncology, Centre Francois Baclesse, Caen, France. · Radiation Oncology, Institut Paoli Calmette, Marseille, France. · Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. · Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. · Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Institut Bergonié, Bordeaux, France. · Institut Claudius Regaud, Toulouse, France. · Hospital Foch, Suresnes, France. · Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France. · Clinique Sainte Marguerite, Hyeres, France. · Centre Hospitalier de la Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Clinique Sainte Catherine, Avignon, France. · R&D UNICANCER, Paris, France; UNICANCER, Paris, France. · Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. · University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. · Pubmed 26576711
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Department of Cancer Medicine, Gustave Roussy, University Paris Sud, 94800 Villejuif, France. Electronic address: · Pubmed 27569040
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 26923772
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, UMR_S 912 (SESSTIM), IRD, Marseille, France; INSERM, UMR_S 912 (SESSTIM), Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · UNICANCER, Paris, France. · Medical Oncology Department, Georges Pompidou Hospital and René Descartes University, Paris, France. · Pubmed 26610858
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 27209539
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer, Los Angeles, CA. Electronic address: · Carolina Urologic Research Center, Myrtle Beach, SC. · Department of Urology, Jikei University School of Medicine, Tokyo, Japan. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25575714
  • Institut Gustave Roussy, Villejuif, France. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Centre François Baclesse, Caen, France. · Institut de Cancérologie de l'Ouest, Angers, France. · Institut Paoli Calmettes, Marseille, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Centre Hospitalier Départemental, La Roche-sur-Yon, France. · Centre Antoine Lacassagne, Nice, France. · Centre Hospitalier de Nimes, Nimes, France. · Institut Claudius Regaud, Toulouse, France. · Hôpital Foch, Paris, France. · Centre Alexis Vautrin, Nancy, France. · Clinique Sainte-Marguerite, Hyères, France. · Centre Hospitalier La Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Centre Léon Bérard, Lyon, France. · Hôpital Saint-André, Bordeaux, France. · Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France. · Hôpital Européen Georges Pompidou, Paris, France. · CHU Dupuytren, Limoges, France. · Centre Henri Becquerel, Rouen, France. · Centre Médical Oncogard, Nimes, France. · Hôpital Henri-Mondor, Créteil, France. · Hôpital Bretonneau, Tours, France. · Hôpital Saint-Joseph, Paris, France. · Institut Curie, Paris, France. · Clinique Sainte-Catherine, Avignon, France. · Unicancer, Paris, France. · Hôpital Saint-Louis, Paris, France. · Pubmed 26028518
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA · Academic Unit of Clinical Oncology, Sheffield Cancer Research Centre, Sheffield, UK. · Division of Urology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada. · Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia. · Department of Electroradiology, Poznan University of Medical Sciences, Poznan Department of Radiotherapy, Wielkopolskie Centrum Onkologii, Poznan, Poland. · St John of God Hospital, Subiaco, Australia. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Department of Hematology/Oncology. · Global Biostatistical Science, Amgen Inc., Thousand Oaks, USA. · Department of Medical Oncology, Institut Gustave Roussy, University of Paris Sud, Paris, France. · Pubmed 25425475
  • Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA · Consulting, Quintiles, Hoofddorp. · Global Data Science, Health Economics & Outcomes Research, Astellas Pharma Global Development, Leiden, The Netherlands. · Health Economics & Clinical Outcomes Research, Astellas Pharma US, Inc., Northbrook, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25361992
  • Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology Department, Centre Eugène Marquis, Rennes, France. · Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology Department, Hôpital Foch, Suresnes, France. · Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology Department, Institut Claudius Régaud, Toulouse, France. · Medical Oncology Department, Institut Curie, Paris, France. · Medical Oncology Department, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France. · Medical Oncology Department, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Pubmed 25277272
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France. Electronic address: · Department of Urology, Lund University, Lund, Sweden, and Malmö University, Malmö, Sweden. · Department of Medical Oncology, University Hospital del Mar, UPF University, Barcelona, Spain. · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · Department of Medical Oncology, Hôpital Saint Louis, Paris, France. · Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Kantonsspital, St. Gallen, Switzerland. · Urologische Klinik und Poliklinik der Technischen Universität, München, Germany. · Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK. · Cancer Research Unit, University of Warwick, Coventry, UK. · Department of Medical Oncology, The Adelaide and Meath Hospital, Dublin, Ireland. · Klinik für Urologie, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Clinic Carl Gustav Carus, Dresden, Germany. · Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Louvain-la-Neuve, Belgium. · Pubmed 25218582
  • Department of Radiation Oncology, Gustave Roussy, Villejuif, France; University Paris Sud, France. Electronic address: · Department of Radiation Oncology, Gustave Roussy, Villejuif, France. · Department of Radiation Oncology, Centre Eugene Marquis, Rennes, France. · Department of Urology, Hôpital Saint Joseph, Paris, France. · Department of Urology, CHU Kremlin-Bicêtre, Kremlin-Bicêtre, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; University Paris Sud, France. · Pubmed 25176583
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
  • Institut Gustave-Roussy, Villejuif, France · University of Virginia, Charlottesville, VA. · Pubmed 26215954
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Institut Paoli-Calmettes, Marseilles, France; Inserm, UMR 912 'Economic & Social Sciences, Health Systems & Societies (SESSTIM)', Aix-Marseille Université, IRD, Marseilles, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology, Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · Medical Oncology, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology, Hôpital Layné, Mont de Marsan, France. · Medical Oncology, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology, Hôpital Bretonneau, Tours, France. · Medical Oncology, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium. · Medical Oncology, Centre Catherine de Sienne, Nantes, France. · Medical Oncology, Hôpital Saint-André, Bordeaux, France. · Medical Oncology, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology, Institut Jean Godinot, Reims, France. · Medical Oncology, Clinique armoricaine de radiologie, Saint-Brieux, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24424105
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. · Institut Jean-Godinot, Reims, France. · Pubmed 25311767
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
  • Irish Cancer Society and University College, Dublin, Ireland. Electronic address: · University Hospital del Mar, Barcelona, Spain. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University Hospital Aachen, Aachen, Germany. · San Camillo and Forlanini Hospital, Rome, Italy. · Centre du Cancer et Institut de Recherche Expérimental et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Hospital Clinic de Barcelona, Barcelona, Spain. · University Hospitals Bristol, Bristol, United Kingdom. · Ospedale San Donato, Istituto Toscano Tumori (ITT), Arezzo, Italy. · University Federico II, Napoli, Italy. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. · St. James's Hospital and Trinity College, Dublin, Ireland. · Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Kantonsspital St. Gallen, St. Gallen, Switzerland. · Tampere University Hospital, Tampere, Finland. · Georges Pompidou European Hospital, Paris, France. · Department of Urology, Academic Medical Center, Amsterdam, The Netherlands. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 24703899
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • From the Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 23714488
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 39 rue Camille Desmoulins, Villejuif, France. · Pubmed 23569308
  • Institut Gustave Roussy and University of Paris XI, 39 Rue Camille Desmoulins, Villejuif, France. · Pubmed 23234632
2012
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22995653
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22129890
  • Institut Gustave Roussy, Villejuif, France. · Pubmed 22119204
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2011
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 21353695
2010
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20353536
2009
  • Institut Gustave Roussy and University of Paris XI, Villejuif, France. · Pubmed 19524963
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19364971
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 19237632
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France, and Charité, Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 19624592
2007
  • Institut Gustave-Roussy, 14, avenue Paul-Vaillant-Couturier, 94800 Villejuif, France. · Pubmed 18297905
  • Department of Medicine, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France. · Pubmed 17426060
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 17942366
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 17322541
2017
  • aDepartment of Radiotherapy, Gustave Roussy, Université Paris-Sud bDepartment of Cancer Medicine, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 28816713
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • From Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); Janssen Research and Development, Los Angeles (N.T.), Beerse, Belgium (P.D.P.), San Diego, CA (T.K.), and Raritan, NJ (Y.C.P.); Instituto de Oncologia de Rosário, Rosário, Argentina (L.F.); National Cancer Center Hospital East, Chiba, Japan (N.M.); 12 de Octubre University Hospital, Madrid (A.R.-A.); P.A. Hertsen Moscow Cancer Research Institute, Moscow (B.Y.A.); Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey (M.Ö.); Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.); Studienpraxis Urologie, Nürtingen, Germany (S.F.); Oxford University Hospitals Foundation NHS Trust, Oxford, United Kingdom (A.P.); Janssen Global Services, Raritan, NJ (M.B.T.); and BC Cancer Agency, Vancouver, Canada (K.N.C.). · Pubmed 28578607
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
2014
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
  • Prostate Cancer Group, INSERM U981, Gustave Roussy, Villejuif, F-94805, France. · Pubmed 24525428
  • Susan Halabi, Chen-Yen Lin, and Ellen B. Kaplan, Duke University; Judd W. Moul, Duke Cancer Institute, Durham, NC; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Karim S. Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Michael J. Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; and Eric J. Small, University of California, San Francisco, San Francisco, CA. · Pubmed 24449231
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, 94800 Villejuif Cedex, France. · Pubmed 23337759
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
  • Prostate Cancer Group, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Pubmed 22745584
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
  • Prostate Cancer Group, INSERM U981, Institut Gustave Roussy, Villejuif F-94805, France. · Pubmed 20974126
2010
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 20483588
  • Département de médecine, Institut Gustave- Roussy, Villejuif, France. · Pubmed 20222324
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
  • Institut Gustave-Roussy, Département de Médecine, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 20022854
  • Department of Radiation, Institut Gustave-Roussy, Villejuif, France. · Pubmed 19825885
2009
  • Institut Gustave-Roussy, 39 bis, rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 19357018
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 18706755
2008
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 18356135
2007
  • Département de Médecine, Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif Cedex. · Pubmed 17845994
Probable:    Universite Paris 11 Sud      
2017
  • MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: · MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. · Salford Royal NHS Foundation Trust, Salford, UK. · Gustave-Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, Villejuif 94800, France. · Janssen Research & Development, San Diego, CA, USA. · Cardiff University, School of Medicine, Cardiff, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28800492
  • SESSTIM, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Medical Oncology Department, Georges Pompidou Hospital, Rene Descartes University, Paris, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · UNICANCER, Paris, France. · Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France; Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28780479
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. Electronic address: · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Oncology Hematology Care, Inc., Cincinnati, OH, USA. · US Oncology, Cancer Centers of North Carolina, Raleigh, NC, USA. · Texas Oncology, Austin, TX, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Uro-Oncology, Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie, Warsaw, Poland. · Celgene Corporation, Summit, NJ, USA. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. · Pubmed 27522164
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: · Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. · Radiation Oncology, Centre Francois Baclesse, Caen, France. · Radiation Oncology, Institut Paoli Calmette, Marseille, France. · Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. · Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. · Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Institut Bergonié, Bordeaux, France. · Institut Claudius Regaud, Toulouse, France. · Hospital Foch, Suresnes, France. · Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France. · Clinique Sainte Marguerite, Hyeres, France. · Centre Hospitalier de la Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Clinique Sainte Catherine, Avignon, France. · R&D UNICANCER, Paris, France; UNICANCER, Paris, France. · Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. · University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. · Pubmed 26576711
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Department of Cancer Medicine, Gustave Roussy, University Paris Sud, 94800 Villejuif, France. Electronic address: · Pubmed 27569040
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, UMR_S 912 (SESSTIM), IRD, Marseille, France; INSERM, UMR_S 912 (SESSTIM), Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · UNICANCER, Paris, France. · Medical Oncology Department, Georges Pompidou Hospital and René Descartes University, Paris, France. · Pubmed 26610858
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 27209539
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Paris, France. · Med Ed, RMC, Exeter, UK. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada · Pubmed 26002607
  • Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer, Los Angeles, CA. Electronic address: · Carolina Urologic Research Center, Myrtle Beach, SC. · Department of Urology, Jikei University School of Medicine, Tokyo, Japan. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25575714
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA · Academic Unit of Clinical Oncology, Sheffield Cancer Research Centre, Sheffield, UK. · Division of Urology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada. · Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia. · Department of Electroradiology, Poznan University of Medical Sciences, Poznan Department of Radiotherapy, Wielkopolskie Centrum Onkologii, Poznan, Poland. · St John of God Hospital, Subiaco, Australia. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Department of Hematology/Oncology. · Global Biostatistical Science, Amgen Inc., Thousand Oaks, USA. · Department of Medical Oncology, Institut Gustave Roussy, University of Paris Sud, Paris, France. · Pubmed 25425475
  • Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA · Consulting, Quintiles, Hoofddorp. · Global Data Science, Health Economics & Outcomes Research, Astellas Pharma Global Development, Leiden, The Netherlands. · Health Economics & Clinical Outcomes Research, Astellas Pharma US, Inc., Northbrook, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25361992
  • Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology Department, Centre Eugène Marquis, Rennes, France. · Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology Department, Hôpital Foch, Suresnes, France. · Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology Department, Institut Claudius Régaud, Toulouse, France. · Medical Oncology Department, Institut Curie, Paris, France. · Medical Oncology Department, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France. · Medical Oncology Department, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Pubmed 25277272
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Department of Radiation Oncology, Gustave Roussy, Villejuif, France; University Paris Sud, France. Electronic address: · Department of Radiation Oncology, Gustave Roussy, Villejuif, France. · Department of Radiation Oncology, Centre Eugene Marquis, Rennes, France. · Department of Urology, Hôpital Saint Joseph, Paris, France. · Department of Urology, CHU Kremlin-Bicêtre, Kremlin-Bicêtre, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; University Paris Sud, France. · Pubmed 25176583
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Institut Paoli-Calmettes, Marseilles, France; Inserm, UMR 912 'Economic & Social Sciences, Health Systems & Societies (SESSTIM)', Aix-Marseille Université, IRD, Marseilles, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology, Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · Medical Oncology, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology, Hôpital Layné, Mont de Marsan, France. · Medical Oncology, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology, Hôpital Bretonneau, Tours, France. · Medical Oncology, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium. · Medical Oncology, Centre Catherine de Sienne, Nantes, France. · Medical Oncology, Hôpital Saint-André, Bordeaux, France. · Medical Oncology, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology, Institut Jean Godinot, Reims, France. · Medical Oncology, Clinique armoricaine de radiologie, Saint-Brieux, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24424105
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
  • Irish Cancer Society and University College, Dublin, Ireland. Electronic address: · University Hospital del Mar, Barcelona, Spain. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University Hospital Aachen, Aachen, Germany. · San Camillo and Forlanini Hospital, Rome, Italy. · Centre du Cancer et Institut de Recherche Expérimental et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Hospital Clinic de Barcelona, Barcelona, Spain. · University Hospitals Bristol, Bristol, United Kingdom. · Ospedale San Donato, Istituto Toscano Tumori (ITT), Arezzo, Italy. · University Federico II, Napoli, Italy. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. · St. James's Hospital and Trinity College, Dublin, Ireland. · Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Kantonsspital St. Gallen, St. Gallen, Switzerland. · Tampere University Hospital, Tampere, Finland. · Georges Pompidou European Hospital, Paris, France. · Department of Urology, Academic Medical Center, Amsterdam, The Netherlands. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 24703899
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • From the Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 23714488
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 39 rue Camille Desmoulins, Villejuif, France. · Pubmed 23569308
  • Institut Gustave Roussy and University of Paris XI, 39 Rue Camille Desmoulins, Villejuif, France. · Pubmed 23234632
2012
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22995653
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22129890
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2011
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 21353695
2010
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20353536
2009
  • Institut Gustave Roussy and University of Paris XI, Villejuif, France. · Pubmed 19524963
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 19237632
  • Department of Medicine, University of Paris XI, Villejuif, France. · Pubmed 19775638
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France, and Charité, Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 19624592
2017
  • aDepartment of Radiotherapy, Gustave Roussy, Université Paris-Sud bDepartment of Cancer Medicine, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 28816713
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • From Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); Janssen Research and Development, Los Angeles (N.T.), Beerse, Belgium (P.D.P.), San Diego, CA (T.K.), and Raritan, NJ (Y.C.P.); Instituto de Oncologia de Rosário, Rosário, Argentina (L.F.); National Cancer Center Hospital East, Chiba, Japan (N.M.); 12 de Octubre University Hospital, Madrid (A.R.-A.); P.A. Hertsen Moscow Cancer Research Institute, Moscow (B.Y.A.); Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey (M.Ö.); Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.); Studienpraxis Urologie, Nürtingen, Germany (S.F.); Oxford University Hospitals Foundation NHS Trust, Oxford, United Kingdom (A.P.); Janssen Global Services, Raritan, NJ (M.B.T.); and BC Cancer Agency, Vancouver, Canada (K.N.C.). · Pubmed 28578607
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia; Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland; Josep M. Piulats, Institut Català d'Oncologia, Barcelona; Javier Puente, Hospital Clínico San Carlos, Madrid, Spain; Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar; Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile; Dirk Jaeger, University Hospital, Heidelberg, Germany; Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil; Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico; Lisa Sengeløv, Herlev Hospital, Herlev, Denmark; M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT; Arvind Varma, DOCS Inc, New York, NY; Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam; and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
2014
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
  • Susan Halabi, Chen-Yen Lin, and Ellen B. Kaplan, Duke University; Judd W. Moul, Duke Cancer Institute, Durham, NC; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Karim S. Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Michael J. Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; and Eric J. Small, University of California, San Francisco, San Francisco, CA. · Pubmed 24449231
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, 94800 Villejuif Cedex, France. · Pubmed 23337759
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
  • Service d'Urologie, Hôpital Bicêtre, 78, rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex, France. · Pubmed 21397833
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
Probable:    Miscellaneous institutions in Paris      
2017
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
2010
  • Service d'urologie, Hôpital Foch, Rue Worth, Suresnes, France. · Pubmed 20493451
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 150 total) written by Karim S. Fizazi about Prostatic Neoplasms:

  • Radiation therapy to the primary in metastatic prostate cancer: palliation only or altering tumor biology? 2017
  • Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis. 2017
  • A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy. 2017
  • Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial. 2017
  • [A randomized controlled trial of metastases-directed treatment in patients with metastatic prostate cancer using stereotactic body irradiation: A GETUG-AFU trial]. 2017
  • Q-TWiST analysis of patients with metastatic castrate naive prostate cancer treated by androgen deprivation therapy with or without docetaxel in the randomised phase III GETUG-AFU 15 trial. 2017
  • Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA. 2017
  • Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. 2017
  • Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer. 2017
  • Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. 2017
Show List of Full Article Records
Google Searches

Learn more about Karim S. Fizazi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
Universite Paris 11 Sud
Miscellaneous institutions in Paris
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Gustave Roussy
2017
  • MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: · MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. · Salford Royal NHS Foundation Trust, Salford, UK. · Gustave-Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, Villejuif 94800, France. · Janssen Research & Development, San Diego, CA, USA. · Cardiff University, School of Medicine, Cardiff, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28800492
  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France. · National Cancer Institute, Vilnius, Lithuania. · Department of Oncology, Herlev Hospital, Herlev. · Department of Oncology, Aalborg University Hospital, Aalborg, Denmark. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · INSERM, UMR1098, Besançon. · Medicine, Centre Léon Bérard, Lyon, France. · Department of Oncology & Hematology, Azienda University Hospital, Modena, Italy. · Dana-Farber/Brigham and Women's Cancer Center, Boston, USA. · Department of Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of General Medical Oncology, University Hospitals Leuven, Leuven. · KU Leuven, Leuven, Belgium. · Urocentrum, Prague, Czech Republic. · General Oncology Department, Centre Oscar Lambret, Lille, France. · Lithuanian University of Health Sciences Hospital, Kaunas, Lithuania. · Gabinet Urologiczny, Gdynia, Gdansk, Poland. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Ipsen Innovation, Les Ulis, France. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Pubmed 29059273
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Département de radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address: · Service de biostatistiques, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Département de radiothérapie, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Groupe d'étude des tumeurs urogénitales, Unicancer, 101, rue de Tolbiac, 75654 Paris cedex 13, France. · Département de médecine oncologique, Gustave-Roussy Cancer Campus, 114, rue Édouard-Vaillant, 94800 Villejuif, France. · Pubmed 28869198
  • SESSTIM, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Medical Oncology Department, Georges Pompidou Hospital, Rene Descartes University, Paris, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · UNICANCER, Paris, France. · Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France; Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28780479
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
  • Department of Cancer Medicine, Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France. · The Royal Marsden National Health Service Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom. · Medivation, Inc, San Francisco, California. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 27648814
  • US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. Electronic address: · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Oncology Hematology Care, Inc., Cincinnati, OH, USA. · US Oncology, Cancer Centers of North Carolina, Raleigh, NC, USA. · Texas Oncology, Austin, TX, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Uro-Oncology, Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie, Warsaw, Poland. · Celgene Corporation, Summit, NJ, USA. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. · Pubmed 27522164
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
  • Institut Gustave Roussy, Villejuif, France · BC Cancer Agency, Vancouver, BC, Canada · Pubmed 29083131
2016
  • MRC Clinical Trials Unit at UCL, London, UK. Electronic address: · MRC Clinical Trials Unit at UCL, London, UK. · Institut Gustave Roussy, Paris, France. · Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Warwick Cancer Research Unit, University of Warwick, Coventry, UK; University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, UK. · Cardiff University School of Medicine, Velindre Hospital, Cardiff, UK. · Lank Center for Genitourinary Cancer, Dana-Farber Cancer Institute, Boston, MA, USA. · Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26718929
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: · Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. · Radiation Oncology, Centre Francois Baclesse, Caen, France. · Radiation Oncology, Institut Paoli Calmette, Marseille, France. · Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. · Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. · Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Institut Bergonié, Bordeaux, France. · Institut Claudius Regaud, Toulouse, France. · Hospital Foch, Suresnes, France. · Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France. · Clinique Sainte Marguerite, Hyeres, France. · Centre Hospitalier de la Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Clinique Sainte Catherine, Avignon, France. · R&D UNICANCER, Paris, France; UNICANCER, Paris, France. · Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. · University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. · Pubmed 26576711
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Department of Cancer Medicine, Gustave Roussy, University Paris Sud, 94800 Villejuif, France. Electronic address: · Pubmed 27569040
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Bergonie Cancer Institute, Bordeaux, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Biopathology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. · INSERM U981, University of Paris-Sud XI, Translational Research Laboratory, Gustave Roussy Cancer Campus, Villejuif, France. · Pubmed 26923772
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, UMR_S 912 (SESSTIM), IRD, Marseille, France; INSERM, UMR_S 912 (SESSTIM), Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · UNICANCER, Paris, France. · Medical Oncology Department, Georges Pompidou Hospital and René Descartes University, Paris, France. · Pubmed 26610858
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 27209539
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer, Los Angeles, CA. Electronic address: · Carolina Urologic Research Center, Myrtle Beach, SC. · Department of Urology, Jikei University School of Medicine, Tokyo, Japan. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25575714
  • Institut Gustave Roussy, Villejuif, France. Electronic address: · Institut Gustave Roussy, Villejuif, France. · Centre François Baclesse, Caen, France. · Institut de Cancérologie de l'Ouest, Angers, France. · Institut Paoli Calmettes, Marseille, France. · Institut de Cancérologie de l'Ouest, Nantes, France. · Centre Hospitalier Départemental, La Roche-sur-Yon, France. · Centre Antoine Lacassagne, Nice, France. · Centre Hospitalier de Nimes, Nimes, France. · Institut Claudius Regaud, Toulouse, France. · Hôpital Foch, Paris, France. · Centre Alexis Vautrin, Nancy, France. · Clinique Sainte-Marguerite, Hyères, France. · Centre Hospitalier La Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Centre Léon Bérard, Lyon, France. · Hôpital Saint-André, Bordeaux, France. · Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France. · Hôpital Européen Georges Pompidou, Paris, France. · CHU Dupuytren, Limoges, France. · Centre Henri Becquerel, Rouen, France. · Centre Médical Oncogard, Nimes, France. · Hôpital Henri-Mondor, Créteil, France. · Hôpital Bretonneau, Tours, France. · Hôpital Saint-Joseph, Paris, France. · Institut Curie, Paris, France. · Clinique Sainte-Catherine, Avignon, France. · Unicancer, Paris, France. · Hôpital Saint-Louis, Paris, France. · Pubmed 26028518
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA · Academic Unit of Clinical Oncology, Sheffield Cancer Research Centre, Sheffield, UK. · Division of Urology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada. · Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia. · Department of Electroradiology, Poznan University of Medical Sciences, Poznan Department of Radiotherapy, Wielkopolskie Centrum Onkologii, Poznan, Poland. · St John of God Hospital, Subiaco, Australia. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Department of Hematology/Oncology. · Global Biostatistical Science, Amgen Inc., Thousand Oaks, USA. · Department of Medical Oncology, Institut Gustave Roussy, University of Paris Sud, Paris, France. · Pubmed 25425475
  • Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA · Consulting, Quintiles, Hoofddorp. · Global Data Science, Health Economics & Outcomes Research, Astellas Pharma Global Development, Leiden, The Netherlands. · Health Economics & Clinical Outcomes Research, Astellas Pharma US, Inc., Northbrook, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25361992
  • Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology Department, Centre Eugène Marquis, Rennes, France. · Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology Department, Hôpital Foch, Suresnes, France. · Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology Department, Institut Claudius Régaud, Toulouse, France. · Medical Oncology Department, Institut Curie, Paris, France. · Medical Oncology Department, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France. · Medical Oncology Department, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Pubmed 25277272
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France. Electronic address: · Department of Urology, Lund University, Lund, Sweden, and Malmö University, Malmö, Sweden. · Department of Medical Oncology, University Hospital del Mar, UPF University, Barcelona, Spain. · Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. · Department of Medical Oncology, Hôpital Saint Louis, Paris, France. · Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, The Netherlands. · Department of Medical Oncology, Kantonsspital, St. Gallen, Switzerland. · Urologische Klinik und Poliklinik der Technischen Universität, München, Germany. · Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK. · Cancer Research Unit, University of Warwick, Coventry, UK. · Department of Medical Oncology, The Adelaide and Meath Hospital, Dublin, Ireland. · Klinik für Urologie, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany. · Department of Urology, University Clinic Carl Gustav Carus, Dresden, Germany. · Service d'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Louvain-la-Neuve, Belgium. · Pubmed 25218582
  • Department of Radiation Oncology, Gustave Roussy, Villejuif, France; University Paris Sud, France. Electronic address: · Department of Radiation Oncology, Gustave Roussy, Villejuif, France. · Department of Radiation Oncology, Centre Eugene Marquis, Rennes, France. · Department of Urology, Hôpital Saint Joseph, Paris, France. · Department of Urology, CHU Kremlin-Bicêtre, Kremlin-Bicêtre, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; University Paris Sud, France. · Pubmed 25176583
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
  • Institut Gustave-Roussy, Villejuif, France · University of Virginia, Charlottesville, VA. · Pubmed 26215954
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Institut Paoli-Calmettes, Marseilles, France; Inserm, UMR 912 'Economic & Social Sciences, Health Systems & Societies (SESSTIM)', Aix-Marseille Université, IRD, Marseilles, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology, Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · Medical Oncology, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology, Hôpital Layné, Mont de Marsan, France. · Medical Oncology, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology, Hôpital Bretonneau, Tours, France. · Medical Oncology, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium. · Medical Oncology, Centre Catherine de Sienne, Nantes, France. · Medical Oncology, Hôpital Saint-André, Bordeaux, France. · Medical Oncology, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology, Institut Jean Godinot, Reims, France. · Medical Oncology, Clinique armoricaine de radiologie, Saint-Brieux, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24424105
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. · Institut Jean-Godinot, Reims, France. · Pubmed 25311767
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
  • Irish Cancer Society and University College, Dublin, Ireland. Electronic address: · University Hospital del Mar, Barcelona, Spain. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University Hospital Aachen, Aachen, Germany. · San Camillo and Forlanini Hospital, Rome, Italy. · Centre du Cancer et Institut de Recherche Expérimental et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Hospital Clinic de Barcelona, Barcelona, Spain. · University Hospitals Bristol, Bristol, United Kingdom. · Ospedale San Donato, Istituto Toscano Tumori (ITT), Arezzo, Italy. · University Federico II, Napoli, Italy. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. · St. James's Hospital and Trinity College, Dublin, Ireland. · Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Kantonsspital St. Gallen, St. Gallen, Switzerland. · Tampere University Hospital, Tampere, Finland. · Georges Pompidou European Hospital, Paris, France. · Department of Urology, Academic Medical Center, Amsterdam, The Netherlands. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 24703899
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • From the Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 23714488
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 39 rue Camille Desmoulins, Villejuif, France. · Pubmed 23569308
  • Institut Gustave Roussy and University of Paris XI, 39 Rue Camille Desmoulins, Villejuif, France. · Pubmed 23234632
2012
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22995653
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22129890
  • Institut Gustave Roussy, Villejuif, France. · Pubmed 22119204
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2011
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 21353695
2010
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20353536
2009
  • Institut Gustave Roussy and University of Paris XI, Villejuif, France. · Pubmed 19524963
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 19364971
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 19237632
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France, and Charité, Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 19624592
2007
  • Institut Gustave-Roussy, 14, avenue Paul-Vaillant-Couturier, 94800 Villejuif, France. · Pubmed 18297905
  • Department of Medicine, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94800 Villejuif, France. · Pubmed 17426060
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 17942366
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 17322541
2017
  • aDepartment of Radiotherapy, Gustave Roussy, Université Paris-Sud bDepartment of Cancer Medicine, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 28816713
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • From Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); Janssen Research and Development, Los Angeles (N.T.), Beerse, Belgium (P.D.P.), San Diego, CA (T.K.), and Raritan, NJ (Y.C.P.); Instituto de Oncologia de Rosário, Rosário, Argentina (L.F.); National Cancer Center Hospital East, Chiba, Japan (N.M.); 12 de Octubre University Hospital, Madrid (A.R.-A.); P.A. Hertsen Moscow Cancer Research Institute, Moscow (B.Y.A.); Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey (M.Ö.); Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.); Studienpraxis Urologie, Nürtingen, Germany (S.F.); Oxford University Hospitals Foundation NHS Trust, Oxford, United Kingdom (A.P.); Janssen Global Services, Raritan, NJ (M.B.T.); and BC Cancer Agency, Vancouver, Canada (K.N.C.). · Pubmed 28578607
  • Wanling Xie, Meredith M. Regan, and Christopher J. Sweeney, Dana-Farber Cancer Institute, Boston, MA; Marc Buyse, International Drug Development Institute; Bertrand Tombal, Université Catholique de Louvain, Louvain-la-Neuve; Laurence Collette, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Susan Halabi, Duke University Medical Center, Durham, NC; Philip W. Kantoff, Memorial Sloan Kettering Cancer Center, New York, NY; Oliver Sartor, Tulane Medical School, New Orleans, LA; Howard Soule, Prostate Cancer Foundation, Santa Monica; Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles, CA; Noel W. Clarke, The Christie NHS Foundation Trust, Manchester; Matthew R. Sydes, University College London, London, United Kingdom; James J. Dignam, University of Chicago, Chicago, IL; Karim Fizazi, Institut Gustave-Roussy, Villejuif, France; Wendy R. Paruleker, Canadian Cancer Trials Group, Kingston, Ontario, Canada; and Scott G. Williams, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28796587
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
2014
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
  • Prostate Cancer Group, INSERM U981, Gustave Roussy, Villejuif, F-94805, France. · Pubmed 24525428
  • Susan Halabi, Chen-Yen Lin, and Ellen B. Kaplan, Duke University; Judd W. Moul, Duke Cancer Institute, Durham, NC; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Karim S. Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Michael J. Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; and Eric J. Small, University of California, San Francisco, San Francisco, CA. · Pubmed 24449231
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, 94800 Villejuif Cedex, France. · Pubmed 23337759
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
  • Prostate Cancer Group, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Pubmed 22745584
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
  • Prostate Cancer Group, INSERM U981, Institut Gustave Roussy, Villejuif F-94805, France. · Pubmed 20974126
2010
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 20483588
  • Département de médecine, Institut Gustave- Roussy, Villejuif, France. · Pubmed 20222324
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
  • Institut Gustave-Roussy, Département de Médecine, 39 Rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 20022854
  • Department of Radiation, Institut Gustave-Roussy, Villejuif, France. · Pubmed 19825885
2009
  • Institut Gustave-Roussy, 39 bis, rue Camille-Desmoulins, 94800 Villejuif, France. · Pubmed 19357018
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 18706755
2008
  • Department of Medicine, Institut Gustave Roussy, Villejuif, France. · Pubmed 18356135
2007
  • Département de Médecine, Institut Gustave-Roussy, 39 rue Camille-Desmoulins, 94805 Villejuif Cedex. · Pubmed 17845994
Universite Paris 11 Sud
2017
  • MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: · MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. · Salford Royal NHS Foundation Trust, Salford, UK. · Gustave-Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, Villejuif 94800, France. · Janssen Research & Development, San Diego, CA, USA. · Cardiff University, School of Medicine, Cardiff, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28800492
  • SESSTIM, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France. Electronic address: · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Medical Oncology Department, Georges Pompidou Hospital, Rene Descartes University, Paris, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · UNICANCER, Paris, France. · Aix-Marseille Université, INSERM, IRD, SESSTIM, Marseille, France; Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Pubmed 28780479
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Department of Drug Development, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Gustave Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA. · Comprehensive Cancer Center Yale School of Medicine, New Haven. · Sanofi Genzyme, Cambridge, USA. · Pubmed 28039155
  • US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. Electronic address: · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA. · Oncology Hematology Care, Inc., Cincinnati, OH, USA. · US Oncology, Cancer Centers of North Carolina, Raleigh, NC, USA. · Texas Oncology, Austin, TX, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Department of Uro-Oncology, Centrum Onkologii - Instytut im Marii Sklodowskiej-Curie, Warsaw, Poland. · Celgene Corporation, Summit, NJ, USA. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. · Pubmed 27522164
  • Institut Gustave Roussy, University of Paris-Sud, Department of Cancer Medicine, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Institut Paoli-Calmettes, Department of Medical Oncology, 13009 Marseille, France. · Pubmed 28428880
  • Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. Electronic address: · University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Pubmed 28314611
  • Duke Cancer Institute, Durham, North Carolina. · Centre Hospitalier de l'Université de Montréal and CRCHUM, Montreal, Quebec, Canada. · Astellas Pharma, Inc., Leiden, Netherlands. · Astellas Pharma, Inc., Northbrook, Illinois. · Carolina Urologic Research Center, Myrtle Beach, South Carolina. · Institut Gustave Roussy, University of Paris Sud, Paris, France. · Medivation, Inc., San Francisco, California. · Sidney Kimmel Center for Prostate and Urologic Cancers and Memorial Sloan-Kettering Cancer Center, New York, New York. · Institute of Cancer Research, London, UK. · Pubmed 28171710
  • The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Centre Hospitalier University of Montréal, Montréal, Québec, Canada. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Johnson & Johnson Medical China, Shanghai, China. · Janssen Global Services, Raritan, NJ, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Pubmed 27402060
2016
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 27151554
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France · University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, USA. · Saarland University, Homburg/Saar, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, San Diego. · Janssen Research & Development, Raritan. · Janssen Global Services, Raritan. · Janssen Research & Development, Los Angeles. · Janssen Research & Development, Menlo Park, USA. · Pubmed 26609008
  • Radiation Oncology, Gustave Roussy Cancer Center, Villejuif, France; University of Paris-Sud, Cancer Campus, Villejuif, France. Electronic address: · Biostatistics, Gustave Roussy Cancer Center, Villejuif, France. · Radiation Oncology, Centre Francois Baclesse, Caen, France. · Radiation Oncology, Institut Paoli Calmette, Marseille, France. · Radiation Oncology, Institut de Cancérologie de l'Ouest, Angers, France. · Centre Hospitalier La Roche sur Yon, La Roche sur Yon, France. · Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Institut Bergonié, Bordeaux, France. · Institut Claudius Regaud, Toulouse, France. · Hospital Foch, Suresnes, France. · Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France. · Clinique Sainte Marguerite, Hyeres, France. · Centre Hospitalier de la Timone, Marseille, France. · Centre Eugène Marquis, Rennes, France. · Clinique Sainte Catherine, Avignon, France. · R&D UNICANCER, Paris, France; UNICANCER, Paris, France. · Department of Medical Oncology, Hopital Saint-Louis, APHP, Paris, France. · University of Paris-Sud, Cancer Campus, Villejuif, France; Department of Cancer Medicine, Gustave Roussy Cancer Center, Villejuif, France. · Pubmed 26576711
  • Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · University of Montréal, Montréal, Québec, Canada. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Monash University and Eastern Health, Victoria, Australia. · ZNA Middelheim Oncology Clinic, Medical Oncology, Antwerp, Belgium. · Churchill Hospital, Oxford, UK. · Janssen Research & Development, Menlo Park, CA, USA. · Janssen Research & Development, Beerse, Belgium. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Georges Pompidou Hospital, University René Descartes, Paris, France. · Pubmed 26508309
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Comprehensive Cancer Center, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland. · Stradins Clinical University Hospital, Riga, Latvia. · Riga East University Hospital, Riga, Latvia. · Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland. · Orion Corporation, Orion Pharma, Espoo, Finland. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 26463318
  • University of Arizona Cancer Center, Tucson, AZ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK Experimental Cancer Medicine Centres, St James's University Hospital, Leeds, UK. · Weston Park Hospital, University of Sheffield, Sheffield, UK. · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. · Center for Comprehensive Gynecology Clinic, Mannheim, Germany. · National Cancer Center Hospital, Tokyo, Japan. · Instituto de Investigación Sanitaria General Gregorio Marañón, Universidad Complutense, Madrid, Spain. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Lancaster Urology, Lancaster, PA, USA. · Urology Associates, Christchurch, New Zealand. · The Urology Center of Colorado, Denver, CO, USA. · Sarah Cannon Research Institute, Nashville, TN, USA. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 26335402
  • Department of Cancer Medicine, Gustave Roussy, University Paris Sud, 94800 Villejuif, France. Electronic address: · Pubmed 27569040
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics, Institut Paoli-Calmettes, Marseille, France; Aix-Marseille Université, UMR_S 912 (SESSTIM), IRD, Marseille, France; INSERM, UMR_S 912 (SESSTIM), Marseille, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · UNICANCER, Paris, France. · Medical Oncology Department, Georges Pompidou Hospital and René Descartes University, Paris, France. · Pubmed 26610858
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Pubmed 27209539
2015
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Pubmed 25922192
  • a Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 114 rue Edouard Vaillant, 94800 Villejuif, France. · Pubmed 26313416
  • Montréal University Health Centre, Montréal, Canada. Electronic address: · Department of Cancer Medicine, Gustave Roussy Institute, University of Paris Sud, Villejuif, France. · Pubmed 26282624
  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA; Department of Clinical Therapeutics, University of Athens, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Genitourinary Medical Oncology, Stanford Alexander Tissue Derivatives Laboratory, David H. Koch Center for Applied Research of Genitourinary Cancers, Houston, TX, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Department of Internal Medicine, Section of Medical Oncology, UAB Medical Center, Birmingham, AL, USA. · Department of Medicine and Urology, Tulane University, New Orleans, LA, USA. · Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada. · Pubmed 26153564
  • Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Paris, France. · Med Ed, RMC, Exeter, UK. · Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada · Pubmed 26002607
  • Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer, Los Angeles, CA. Electronic address: · Carolina Urologic Research Center, Myrtle Beach, SC. · Department of Urology, Jikei University School of Medicine, Tokyo, Japan. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25575714
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Department of Urology, Guys and St Thomas' Hospital, London, UK. · Department of Medicine, Division of Medical Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Early Clinical Development, Medivation, San Francisco, CA, USA. · Health Economics and Outcomes Research, Astellas Pharma Europe, Leiden, Netherlands. · Department of Medical Affairs, Medivation, San Francisco, CA, USA. · Astellas Pharma Global Development, Northbrook, IL, USA. · Consulting, Quintiles, Hoofddorp, Netherlands. · Consulting, Quintiles, Barcelona, Spain; Department of Public Health, University of Barcelona, Barcelona, Spain. · Division of Hematology and Medical Oncology, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Department of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. · Pubmed 25888263
  • Yale Cancer Center, Department of Medicine Division of Oncology, New Haven, CT, USA. Electronic address: · US Oncology Research, Houston, TX, USA; Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · NSHI Dorozhnaya Clinical Hospital of OAO Russian Railways, Rostov-on-Don, Russia. · Department of Uro-Oncology, Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland. · San Camillo and Forlanini Hospitals, Department of Medical Oncology, Rome, Italy. · Texas Oncology, Austin, TX, USA. · University Hospital del Mar-IMIM, Barcelona, Spain; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · US Oncology Research, Houston, TX, USA; Rocky Mountain Cancer Centers, Aurora, CO, USA. · Catalan Institute of Oncology, Department of Medical Oncology, Barcelona, Spain. · Department of Clinical Oncology, The Christie NHS Foundation Trust and Institute of Cancer Sciences, University of Manchester, Manchester, UK. · Department of Urology, Rechts der Isar Medical Center, Technische Universität München, München, Germany. · State Institution of Healthcare "Regional Clinical Oncology Dispensary", Omsk, Russia. · Centre Léon Bérard, Department of Medical Oncology, Lyon, France. · Department of Clinical Oncology, Royal Marsden Hospital, London, UK. · Medical Oncology Department, Groupe Hospitalier Universitaire Caremeau Place du Professeur Robert Debré, Nîmes, France. · Celgene Corporation, Summit, NJ, USA. · ErasmusMC Cancer Institute, Rotterdam, Netherlands. · Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France. · Pubmed 25743937
  • Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Universitatea de Medicina si Farmacie, Bucharest, Romania. · University of Athens Medical School, Athens, Greece. · Auckland City Hospital, Auckland, New Zealand. · Florida Cancer Specialists, Fort Myers, FL, USA. · Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. · The Adelaide and Meath Hospital, Incorporating the National Children's Hospital, Dublin, Ireland. · University Hospital Carl Gustav Carus Dresden, Dresden, Germany. · Gunma University Graduate School of Medicine, Gunma, Japan. · Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA. · The University of Tokyo Research Center for Advanced Science and Technology, Tokyo, Japan. · University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Cleveland Clinic, Cleveland, OH, USA. · Millennium Pharmaceuticals, Inc, Cambridge, MA, USA. · Erasmus University Medical Center, Rotterdam, Netherlands. · Pubmed 25701170
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University of Montréal, Montréal, Québec, Canada. · Radboud University Medical Centre, Nijmegen, Netherlands. · San Camillo and Forlanini Hospitals, Rome, Italy. · Charité Berlin, Berlin, Germany. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · University of Western Sydney School of Medicine and Ingham Institute, Liverpool, Australia. · The Institute of Cancer Research and the Royal Marsden Hospital, Sutton, United Kingdom. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Pubmed 25601341
  • The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada. · Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada. · Ziekenhuisnetwerk Antwerpen-Middelheim Oncology Clinic, Antwerp, Belgium. · VU University Medical Center, Amsterdam, the Netherlands. · Janssen Research and Development, Spring House, Pennsylvania. · Janssen Research and Development, Menlo Park, California. · Janssen Research and Development, Los Angeles, California. · Janssen Research and Development, San Diego, California. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California. · Pubmed 25593303
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Nyack Hospital, Nyack, NY, USA. · Cancer Research UK Experimental Cancer Medicine Centres, Leeds and Sheffield, UK. · Department of Radiotherapy, Greater Poland Cancer Center and Department of Electroradiology, Medical University, Poznań, Poland. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · European Georges Pompidou Hospital, Paris, France. · The Urology Center of Colorado, Denver, CO, USA. · Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA. · Universitario Pedro Ernesto, Rio De Janeiro, Brazil. · Amgen Inc., Thousand Oaks, CA, USA. · Pubmed 25449207
  • Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA · Academic Unit of Clinical Oncology, Sheffield Cancer Research Centre, Sheffield, UK. · Division of Urology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada. · Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia. · Department of Electroradiology, Poznan University of Medical Sciences, Poznan Department of Radiotherapy, Wielkopolskie Centrum Onkologii, Poznan, Poland. · St John of God Hospital, Subiaco, Australia. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Department of Hematology/Oncology. · Global Biostatistical Science, Amgen Inc., Thousand Oaks, USA. · Department of Medical Oncology, Institut Gustave Roussy, University of Paris Sud, Paris, France. · Pubmed 25425475
  • Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, USA · Consulting, Quintiles, Hoofddorp. · Global Data Science, Health Economics & Outcomes Research, Astellas Pharma Global Development, Leiden, The Netherlands. · Health Economics & Clinical Outcomes Research, Astellas Pharma US, Inc., Northbrook, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 25361992
  • Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France. · Medical Oncology Department, Centre Eugène Marquis, Rennes, France. · Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France. · Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology Department, Hôpital Foch, Suresnes, France. · Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology Department, Centre Antoine Lacassagne, Nice, France. · Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology Department, Institut Claudius Régaud, Toulouse, France. · Medical Oncology Department, Institut Curie, Paris, France. · Medical Oncology Department, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology Department, Hôpital Layné, Mont de Marsan, France. · Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology Department, Hôpital Bretonneau, Tours, France. · Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. · Medical Oncology Department, Centre Catherine de Sienne, Nantes, France. · Medical Oncology Department, Hôpital Saint-André, Bordeaux, France. · Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology Department, Institut Jean Godinot, Reims, France. · Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France. · Medical Oncology Department, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Pubmed 25277272
  • University of Montreal Hospital Centre, Montreal, QC, Canada. Electronic address: · Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, UK. · Carolina Urologic Research Center, Myrtle Beach, SC, USA. · Gustave Roussy, Cancer Campus Grand Paris, University of Paris Sud, Villejuif, France. · Medivation, Inc., San Francisco, CA, USA. · Astellas Global Medical Affairs, Inc., Northbrook, IL, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 25171902
  • Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. Electronic address: · Department of Biostatistics and Epidemiology, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, University of Paris Sud, France. · Department of Ambulatory Care, Gustave-Roussy Cancer Campus, University of Paris Sud, Villejuif, France. · Pubmed 26278649
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Institut Jean Godinot, Reims, France. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Pubmed 26208462
  • Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland. · Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Biostatistics and Bioinformatics, Duke University, Durham. · Division of Human Biology, Fred Hutchinson Cancer Research Centre, Seattle. · Tulane Cancer Centre, Tulane University, New Orleans. · Massachusetts General Hospital Cancer Centre, Boston. · Prostate Cancer Foundation, Santa Monica, USA. · Research Centre for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan. · Oregon Health & Science University Knight Cancer Institute, Portland. · Department of Medicine, Weill Cornell Medical College, New York. · Michigan Centre for Translational Pathology, Department of Pathology Department of Urology, Comprehensive Cancer Centre Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, USA. · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. · Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia. · Cancer Research Centre, University of Warwick, Warwick, UK Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Johns Hopkins Sidney Kimmel Cancer Center and The Brady Urological Institute, Department of Urology, Johns Hopkins University School of Medicine, Baltimore, USA. · The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. · Department of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy. · Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Klinik und Poliklinik für Urologie, RWTH University Aachen, Aachen, Germany. · University of Michigan Comprehensive Cancer Center, Ann Arbor, USA. · Cancer Research Centre, University of Warwick, Warwick, UK Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, Birmingham, UK. · Department of Radiology, Centre du Cancer et Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston Department of Genitourinary Medical Oncology, David H. Koch Centre, The University of Texas M. D. Anderson Cancer Centre, Houston, USA. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. · Division of Haematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA. · Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid CNIO-IBIMA Genitourinary Cancer Unit, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain. · Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood. · Prostate Cancer Targeted Therapy Group, Academic Urology Unit and Department of Diagnostic Radiology, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, UK. · Institute for Precision Medicine, Meyer Cancer Center, Department of Pathology and Urology, Weill Cornell Medical College and NewYork Presbyterian, New York, USA. · Department of Urology, Radboud University, Medical Centre, Nijmegen, The Netherlands. · Department of Medicine, Weill Cornell Medical College, New York Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York. · Department of Oncology, Assaf Harofeh Medical Centre, Tel-Aviv University, Sackler School of Medicine, Zerifin, Israel. · Department of Urology, Carolina Urologic Research Centre, Myrtle Beach. · Helen Diller Family Comprehensive Cancer Centre, UCSF, San Francisco, USA. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Urology, Toho University Sakura Medical Center, Chiba, Japan. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada. · Service D'Urologie, Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 26041764
  • University of Montréal, Montréal, Québec, Canada. Electronic address: · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University Hospital Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · MD Anderson Cancer Center, Houston, TX, USA. · University of Western Sydney School of Medicine, Ingham Institute, Liverpool, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology and Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, San Diego, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Janssen Research & Development, Menlo Park, CA, USA. · Pubmed 25985882
  • Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Urology, University Hospital of Pointe-à-Pitre, France. · Department of Urology, Kremlin-Bicêtre Hospital, University of Paris-Sud, Kremlin-Bicêtre, France. · Department of Urology, Saint-Joseph Hospital, Paris, France. · Department of Radiotherapy, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. · Department of Forestry and Management of the Environment and Natural Resources, School of Agricultural Sciences and Forestry, Democritus University, Alexandroupoli, Greece. · Department of Cancer Medicine, Gustave Roussy Institute, Cancer Campus, Grand Paris, University of Paris-Sud, Villejuif, France. Electronic address: · Pubmed 25746940
  • Department of Radiation Oncology, Gustave Roussy, Villejuif, France; University Paris Sud, France. Electronic address: · Department of Radiation Oncology, Gustave Roussy, Villejuif, France. · Department of Radiation Oncology, Centre Eugene Marquis, Rennes, France. · Department of Urology, Hôpital Saint Joseph, Paris, France. · Department of Urology, CHU Kremlin-Bicêtre, Kremlin-Bicêtre, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; University Paris Sud, France. · Pubmed 25176583
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2014
  • Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France. · Department of Cancer Medicine, Institut Gustave Roussy and University of Paris Sud, Villejuif, France; Drug Development Department, SITEP, Institut Gustave Roussy, Villejuif, France. Electronic address: · Pubmed 24735730
  • Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: · Academic Unit of Clinical Oncology, Weston Park Hospital, CR-UK/YCR Sheffield Cancer Research Centre, Sheffield, UK. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Urology, University Hospital Charité, Berlin, Germany. · Division of Urology, Centre Hospitalier de l'Université de Montréal, CRCHUM, Montréal, QC, Canada. · Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy. · Tisch Cancer Center Institute, Mount Sinai School of Medicine, New York, NY, USA. · Pubmed 23706567
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Charité Berlin, Berlin, Germany. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · San Camillo and Forlanini Hospitals, Rome, Italy. · Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Medivation, San Francisco, CA, USA. · Royal Marsden Hospital and the Institute of Cancer Research, Sutton, UK. · Pubmed 25104109
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Cancer Center, Helsinki University Central Hospital, Helsinki, Finland. · Velindre Cancer Centre, Cardiff, UK. · Kuopio University Hospital, Kuopio, Finland. · Queen Elizabeth Hospital, Birmingham, UK. · Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA. · Churchill Hospital, Oxford, UK. · Tampere University Hospital, Tampere, Finland. · Christie Hospital NHS, Manchester, UK. · Orion Corporation Orion Pharma, Espoo, Finland. · Endo Pharmaceuticals, Malvern, USA. · Pubmed 24974051
  • Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA. Electronic address: · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Institut Gustave Roussy, University of Paris-Sud, Villejuif, France. · Institut Gustave Roussy, Villejuif, France. · VU University Medical Centre, Amsterdam, Netherlands. · Vienna General Hospital, Medical University Vienna, Vienna, Austria. · Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France. · Centro Médico Austral, Buenos Aires, Argentina. · Centre Jean Perrin, Clermont-Ferrand, France. · St John of God Hospital, Subiaco, WA, Australia. · University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Hospital de Caridade de Ijuí, Ijuí, Brazil. · Nottingham University Hospital, Nottingham, UK. · Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania. · Hospital Británico de Buenos Aires, Buenos Aires, Argentina. · Herlev Hospital, Herlev, Denmark. · Odense University Hospital, Odense, Denmark. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Bristol-Myers Squibb, Wallingford, CT, USA. · Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands. · Pubmed 24831977
  • Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: · Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA. · The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · University of Western Sydney School of Medicine, Penrith, Australia. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Hematology & Oncology Clinics of Australia, Brisbane, Australia. · Sarah Cannon Research Institute, Nashville, TN, USA. · Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA. · Cross Cancer Institute, Edmonton, Alberta, Canada. · Laval University, Québec City, Québec, Canada. · University Hospital Leuven, Leuven, Belgium. · Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. · University of Colorado Cancer Center and University of Colorado School of Medicine, Aurora, CO, USA. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Janssen Research & Development, Menlo Park, CA, USA. · CRCHUM, University of Montréal, Montréal, Québec, Canada. · Pubmed 24647231
  • Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Electronic address: · Institut Paoli-Calmettes, Marseilles, France; Inserm, UMR 912 'Economic & Social Sciences, Health Systems & Societies (SESSTIM)', Aix-Marseille Université, IRD, Marseilles, France. · Medical Oncology, Centre François Baclesse - CHU Côte de Nacre, Caen, France. · Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France. · Medical Oncology, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France. · Biostatistic, Institut Paoli-Calmettes, Marseille, France. · Radiotherapy Department, Clinique Pasteur, Toulouse, France. · Department of Medical Oncology, Centre Paul Papin, Angers, France. · Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-nancy, France. · Medical Oncology, Centre Eugène Marquis, Rennes, France. · Medical Oncology, Centre René Gauducheau, Saint-Herblain, France. · Medical Oncology, Hôpital Foch, Suresnes, France. · Medical Oncology, Groupe Hospitalier Saint Joseph, Paris, France. · Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Medical Oncology, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France. · Medical Oncology, Institut Claudius Régaud, Toulouse, France. · Medical Oncology, Institut Curie, Paris, France. · Medical Oncology, Centre Georges François Leclerc, Dijon, France. · R&D UNICANCER, Paris cedex 13, France. · Medical Oncology, Clinique Sainte Marguerite, Hyeres, France. · Medical Oncology, Hôpital Layné, Mont de Marsan, France. · Medical Oncology, Centre Hospitalier La Timone, Marseille, France. · Medical Oncology, Centre Régional Hospitalier, Metz-Thionville, France. · Medical Oncology, Hôpital Bretonneau, Tours, France. · Medical Oncology, Centre Hospitalier Dupuytren, Limoges, France. · Medical Oncology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium. · Medical Oncology, Centre Catherine de Sienne, Nantes, France. · Medical Oncology, Hôpital Saint-André, Bordeaux, France. · Medical Oncology, Clinique Saint-Jean Languedoc, Toulouse, France. · Medical Oncology, Institut Jean Godinot, Reims, France. · Medical Oncology, Clinique armoricaine de radiologie, Saint-Brieux, France. · Medical Oncology, Hôpital Saint-Louis, Paris, France. · Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24424105
  • Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Radboud University Medical Centre, Nijmegen, The Netherlands. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Urologikum Hamburg, Hamburg, Germany. · Janssen Research & Development, Raritan, NJ, USA. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Memorial Sloan-Kettering Cancer Center and Weill-Cornell Medical College, New York, NY, USA. · Pubmed 24080993
  • Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. · Department of Medicine, Centre Léon Bérard, Lyon, France. · Department of Internal Medicine, Istanbul University Hospitals, Istanbul, Turkey. · Stat Process, Port-Mort, France. · Department of Medicine, Institut de Cancérologie de la Loire, Saint-Etienne, France. · Department of Medical Oncology, Val de Grace Hospital, Paris, France. · Department of Medicine, Institut Paoli Calmettes, Marseille, France. · Department of Medicine, Institut Curie, Paris, France. · Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Department of Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France. · Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. Electronic address: · Pubmed 24725337
  • Irish Cancer Society and University College, Dublin, Ireland. Electronic address: · University Hospital del Mar, Barcelona, Spain. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · University Hospital Aachen, Aachen, Germany. · San Camillo and Forlanini Hospital, Rome, Italy. · Centre du Cancer et Institut de Recherche Expérimental et Clinique (IREC), Cliniques Universitaires Saint Luc, Brussels, Belgium. · Hospital Clinic de Barcelona, Barcelona, Spain. · University Hospitals Bristol, Bristol, United Kingdom. · Ospedale San Donato, Istituto Toscano Tumori (ITT), Arezzo, Italy. · University Federico II, Napoli, Italy. · University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States. · St. James's Hospital and Trinity College, Dublin, Ireland. · Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · Kantonsspital St. Gallen, St. Gallen, Switzerland. · Tampere University Hospital, Tampere, Finland. · Georges Pompidou European Hospital, Paris, France. · Department of Urology, Academic Medical Center, Amsterdam, The Netherlands. · Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef-Spital, Vienna, Austria. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Erasmus University Medical Center, Rotterdam, The Netherlands. · Pubmed 24703899
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • From the Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 23714488
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, 39 rue Camille Desmoulins, Villejuif, France. · Pubmed 23569308
  • Institut Gustave Roussy and University of Paris XI, 39 Rue Camille Desmoulins, Villejuif, France. · Pubmed 23234632
2012
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22995653
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22129890
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif 94800, France. · Pubmed 22987974
2011
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 21353695
2010
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20353536
2009
  • Institut Gustave Roussy and University of Paris XI, Villejuif, France. · Pubmed 19524963
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 19237632
  • Department of Medicine, University of Paris XI, Villejuif, France. · Pubmed 19775638
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France, and Charité, Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 19624592
2017
  • aDepartment of Radiotherapy, Gustave Roussy, Université Paris-Sud bDepartment of Cancer Medicine, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Pubmed 28816713
  • Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada; Marie Hjälm-Eriksson, Karolinska University Hospital, Stockholm, Sweden; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Orazio Caffo, Santa Chiara Hospital, Trento, Italy; Daniel Castellano, University Hospital 12 de Octubre, Madrid, Spain; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; John Bernard, Sanofi, Cambridge, MA; Liji Shen, Sanofi, Bridgewater, NJ; and Oliver Sartor, Tulane Cancer Center, New Orleans, LA. · Pubmed 28753384
  • From Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); Janssen Research and Development, Los Angeles (N.T.), Beerse, Belgium (P.D.P.), San Diego, CA (T.K.), and Raritan, NJ (Y.C.P.); Instituto de Oncologia de Rosário, Rosário, Argentina (L.F.); National Cancer Center Hospital East, Chiba, Japan (N.M.); 12 de Octubre University Hospital, Madrid (A.R.-A.); P.A. Hertsen Moscow Cancer Research Institute, Moscow (B.Y.A.); Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey (M.Ö.); Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.); Studienpraxis Urologie, Nürtingen, Germany (S.F.); Oxford University Hospitals Foundation NHS Trust, Oxford, United Kingdom (A.P.); Janssen Global Services, Raritan, NJ (M.B.T.); and BC Cancer Agency, Vancouver, Canada (K.N.C.). · Pubmed 28578607
  • Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis, Adelaide Cancer Centre, Adelaide, South Australia, Australia; Jonathan Polikoff, Southern California Permanente Medical Group, San Marcos, CA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Piotr Humanski, Niepubliczny Zaklad Opieki Zdrowotnej Specjalista, Kutno, Poland; Josep M. Piulats, Institut Català d'Oncologia, Barcelona; Javier Puente, Hospital Clínico San Carlos, Madrid, Spain; Pablo Gonzalez Mella, Instituto Oncologico, Viña del Mar; Pablo Gonzalez Mella, Fundación Arturo Lopez Pérez, Santiago, Chile; Dirk Jaeger, University Hospital, Heidelberg, Germany; Fabio A. Franke, Hospital de Caridade de Ijuí, Ijuí, Brazil; Roman Carvajal, Hospital Regional Valentin Gomez Farias, Zapopan, Mexico; Lisa Sengeløv, Herlev Hospital, Herlev, Denmark; M. Brent McHenry, Bristol-Myers Squibb, Wallingford, CT; Arvind Varma, DOCS Inc, New York, NY; Alfonsus J. van den Eertwegh, VU University Medical Center, Amsterdam; and Winald Gerritsen, Radboud University, Nijmegen, the Netherlands. · Pubmed 28034081
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
  • Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
2015
  • Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Michael J. Morris, Steven M. Larson, and Howard I. Scher, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Arturo Molina, Thian Kheoh, Shannon L. Matheny, Vahid Naini, and Thomas W. Griffin, Janssen Research & Development, Los Angeles; Eric J. Small and Charles J. Ryan, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA; Johann S. de Bono, Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom; Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Paul de Souza, University of Western Sydney School of Medicine, Ingham Institute, Liverpool, New South Wales, Australia; Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Celestia S. Higano, University of Washington, Seattle, WA; Jinhui Li, Janssen Research & Development, Raritan, NJ; and Tomasz Burzykowski, International Drug Development Institute, Louvain-la-Neuve, Belgium. · Pubmed 25624432
  • Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal, Canada; Ronald de Wit, Erasmus University Medical Center, Rotterdam, the Netherlands; Felipe Melo Cruz, ABC Foundation School of Medicine, Santo André; Flavio Carcano, Hospital de Cancer de Barretos, Barretos, Brazil; Albertas Ulys, Institut of Oncology, Vilnius University, Vilnius, Lithuania; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; David Agus, University of Southern California, Los Angeles, CA; Daniel P. Petrylak, Yale University Cancer Center, New Haven, CT; Shih-Yuan Lee, Bindu Tejura, Niels Borgstein, Takeda Pharmaceuticals International; Iain J. Webb, Millennium: The Takeda Oncology Company, Cambridge, MA; Robert Dreicer, Cleveland Clinic, Cleveland, OH; Joaquim Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain. · Pubmed 25624429
2014
  • Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris Sud, Villejuif, France. · Pubmed 24075577
  • Institute Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Villejuif, France, · Pubmed 24771350
  • Susan Halabi, Chen-Yen Lin, and Ellen B. Kaplan, Duke University; Judd W. Moul, Duke Cancer Institute, Durham, NC; W. Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Karim S. Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Michael J. Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; and Eric J. Small, University of California, San Francisco, San Francisco, CA. · Pubmed 24449231
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, 94800 Villejuif Cedex, France. · Pubmed 23337759
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2012
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 22267211
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
  • Service d'Urologie, Hôpital Bicêtre, 78, rue du Général Leclerc, 94275 Le Kremlin-Bicêtre Cedex, France. · Pubmed 21397833
2010
  • Department of Medicine, Institut Gustave Roussy, University of Paris XI, Villejuif, France. · Pubmed 20181574
Miscellaneous institutions in Paris
2017
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Cancer Medicine, Institute Gustave Roussy, Villejuif, France. · Department of Oncology, University of Paris, Paris, France. · Janssen Oncology Research & Development, Raritan, New Jersey. · Janssen Research & Development, Menlo Park, California. · Millennium Pharmaceuticals Inc., Cambridge, Massachusetts. · Department of Surgery, University of Montréal, Montréal, Québec, Canada. · Prostate Cancer Targeted Therapy Group, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 27678453
2010
  • Service d'urologie, Hôpital Foch, Rue Worth, Suresnes, France. · Pubmed 20493451
Miscellaneous institutions in Villejuif
2016
  • Gustave Roussy, Université Paris-Saclay, Department of Medicine, F-94805, Villejuif, France. · INSERM, U981 "Identification of Molecular Predictors and New Targets for Cancer Treatment", F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Circulating Tumor Cells" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Hôpital d'Instruction des Armées du Val de Grâce, Department of Oncology, F-75005, Paris, France. · Gustave Roussy, Université Paris-Saclay, Department of Biopathology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, Department of Biostatistics and Epidemiology, F-94805, Villejuif, France. · Gustave Roussy, Université Paris-Saclay, "Histo Cytopathology" Translational Platform, AMMICA CNRS UMS3655 - INSERM US23, F-94805, Villejuif, France. · Pubmed 27391263
INSERM Paris
2015
  • Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, Val de Grâce Hospital, Paris, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, CHU de Bordeaux, Bordeaux, France. · Pitié-Salpetrière Hospital, Paris, France. · Institut de Cancérologie de la Loire, Saint-Etienne, France. · Biostatistics and Epidemiology unit, Institut Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France. · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Department of Cancer Medicine, Gustave Roussy, Cancer Campus, Grand Paris, University of Paris-Sud, and INSERM U981, Villejuif, France. Electronic address: · Pubmed 24837187
2013
  • Department of Cancer Medicine, Institut Gustave Roussy, University of Paris-Sud, INSERM 981, Villejuif, France. · Pubmed 23576708
2011
  • Institut Gustave Roussy, Department of Cancer Medicine, University of Paris Sud, Unité INSERM U981, Paris, France. · Pubmed 21680543
Charite-Universitatsmedizin
2009
  • Institut Gustave Roussy, University of Paris XI, Villejuif, France, and Charité, Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 19624592
2016
  • Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia. · Pubmed 27400947
2013
  • Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany. · Pubmed 23381694
  • Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; Ronaldo Damiao, Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; Gavin Marx, Sydney Haematology and Oncology Clinic, University of Sydney, Wahroonga, New South Wales, Australia; Kurt Miller, Charité Berlin, Berlin, Germany; Peter Van Veldhuizen, Kansas City Veterans Affairs Medical Center, Kansas City, MO; Juan Morote, Hospital Vall d'Hebron, Barcelona, Spain; and Zhishen Ye, Roger Dansey, and Carsten Goessl, Amgen, Thousand Oaks, CA. · Pubmed 24043751
99 Other Locations Show
Yearly article counts 0201730181712991125